|
|
Volumn 33, Issue 7-8, 2001, Pages 3169-3171
|
|
Interleukin-2 receptor monoclonal antibodies in renal transplantation: Current use and emerging regimens
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CALCINEURIN INHIBITOR;
CYCLOSPORIN A;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PLACEBO;
PREDNISONE;
RAPAMYCIN;
STEROID;
TACROLIMUS;
CADAVER KIDNEY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
CREATININE BLOOD LEVEL;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG DISPOSITION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERANCE;
EDITORIAL;
FOLLOW UP;
GRAFT SURVIVAL;
HLA MATCHING;
HUMAN;
HYPERLIPIDEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY BIOPSY;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE;
MAINTENANCE THERAPY;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
|
|
EID: 0035678962
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02349-1 Document Type: Article |
|
Times cited : (9)
|
|
References (8)
|
